ANAB Competitors & Alternatives
Compare AnaptysBio Inc with similar stocks in the same industry
Biotechnology
ANAB
Main Stock$48.28
Tradestie Score
53
Market Cap
$894.30M
Revenue Growth
0.2%
Analyst Upside
+80.7%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$90.71
|
$1.55B | - | 41 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$33.95
|
$1.55B | 11.1 | 61 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$34.16
|
$1.55B | - | 44 | Compare |
|
NVAX
Novavax Inc
|
$9.13
|
$1.54B | - | 57 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.32
|
$1.50B | 7.1 | 54 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$20.02
|
$1.50B | - | 40 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$30.73
|
$1.49B | - | 39 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.18
|
$1.43B | - | 61 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$11.68
|
$1.42B | - | 42 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.50
|
$1.35B | - | 58 | Compare |
More ANAB Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry